International Journal of Transgender Health

Assessment of breast and prostate cancer risk in trans and gender diverse individuals receiving gender-affirming hormone therapy

By Jiping Wang, Zhenlin Yang, Max Heiland, Robert Preißner

Cohort study of 22,338 peoplePopulations

The paper

Jiping Wang, Zhenlin Yang, Max Heiland, Robert Preißner

China Scholarship Council; Charité - Universitätsmedizin Berlin

International Journal of Transgender Health, 10 Sep 2025, CC BY-NC

doi.org/10.1080/26895269.2025.2551143 PubMed 42807481

International Journal of Cancer10 Oct 2026
Cancer survivors face more illnesses, especially with low education
medRxiv4 Oct 2026
Estrogen-responsive variants interact with reproductive risk factors
JAMA Otolaryngology-- Head & Neck Surgery4 Oct 2026
5-ARI use is tied to lower laryngeal cancer risk in men
medRxiv6 Oct 2026
Hormone therapy linked to lower breast cancer mortality